NASDAQ:LVTX
Delisted

Lava Therapeutics B.v Stock Predictions

etoro logo Buy LVTX
*Your capital is at risk
$1.74
+0 (+0%)
At Close: Feb 27, 2026
Currently predicting for Fri, 5 Jun 2026

LVTX Prediction Chart

LVTX Predictions History

Latest community submissions for LVTX.
Predictor Target Session Target Price Result Direction Accuracy Score
BullishBunny89 BullishBunny89 Amateur
Jun 27, 2023 Bullish $2.07 X 0
JS JS Pro
Jun 26, 2023 $2.13 -0.93% $2.13 V 100.00% 10
Jun 26, 2023 $2.06 -4.27% $2.13 V 96.63% 1
Jun 26, 2023 $2.09 -2.67% $2.13 V 98.24% 1
BullishBunny89 BullishBunny89 Amateur
Jun 26, 2023 Bullish $2.13 X 0
JS JS Pro
Jun 15, 2023 $2.13 -0.93% $1.96 V 91.33% 1
Jun 15, 2023 $2.26 +5.11% $1.96 X 84.70% 0
Jun 15, 2023 $2.22 +3.19% $1.96 X 86.80% 0
Jun 15, 2023 Bullish $1.96 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for LVTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT LAVA THERAPEUTICS B.V.
Lava Therapeutics B.V
LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer patients. Its lead clinical-stage candidates are LAVA-051, which is in Phase 1/2a clinical trial for b...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE